Pregnancy, fetal, and neonatal outcomes after a first booster dose of covid-19 vaccine during pregnancy in Ontario, Canada: population based, retrospective cohort study.

Deshayne B FellSheryll Dimanlig-CruzEszter TörökSiri E HåbergAnnette K ReganJay S KaufmanRobert W PlattChristopher A GravelLiam BrucePrakesh S ShahKumanan WilsonAnn E SpragueGillian D AltonTavleen DhinsaDarine El-ChaârSarah A BuchanJeffrey C KwongSarah E WilsonSandra I DunnShannon E MacDonaldJon BarrettNannette OkunMark C Walker

Published in: BMJ medicine (2023)

Receipt of a third covid-19 vaccine dose during pregnancy was not associated with an increased risk of adverse pregnancy, fetal, or neonatal outcomes. These findings can help to inform evidence based decision making about the risks and benefits of covid-19 booster doses during pregnancy.

Keyphrases

coronavirus disease
sars cov
decision making
preterm birth
respiratory syndrome coronavirus
type diabetes
emergency department
metabolic syndrome
skeletal muscle